Descripción de la empresa
Ardent Health, Inc. operates a comprehensive network of hospitals and clinics delivering general and specialty healthcare services throughout the United States, encompassing disciplines such as internal medicine, cardiology, oncology, and orthopedics. The company functions within the broader Healthcare sector, specifically categorized under the Medical Care Facilities industry, positioning it as a key provider of essential medical infrastructure and patient care services. This enterprise employs approximately 19,500 individuals and maintains a total market capitalization of $1.29 billion, while reporting trailing twelve-month revenue of $6.32 billion. These financial metrics indicate a substantial operational footprint and significant revenue generation capacity, suggesting that Ardent Health commands a considerable presence within the competitive landscape of U.S. healthcare delivery systems.
Salud financiera
The company reported total revenue of $6.32 billion over the trailing twelve months, with net income of $135.81 million and EBITDA reaching $481.29 million, highlighting a distinct gap between top-line revenue and bottom-line earnings that underscores a substantial cost structure comprising operating expenses, taxes, and interest. While EBITDA reflects cash earnings before interest, taxes, depreciation, and amortization, the net income figure demonstrates that after all obligations are met, the company retains a profit margin that is sensitive to its overhead costs. The business maintains a gross margin of 58.0%, indicating strong pricing power or efficient direct cost management relative to revenue, yet the operating margin sits at 6.5%, revealing that general and administrative expenses absorb a significant portion of the gross profit. The profit margin further narrows to 2.1%, signaling that the company operates with thin profitability where small changes in operational efficiency or market conditions can materially impact overall earnings. Regarding liquidity and leverage, Ardent Health holds $712.49 million in cash against a total debt load of $2.32 billion, resulting in a debt-to-equity ratio of 137.57 which characterizes the balance sheet as heavily leveraged rather than conservative. Despite the high leverage, the current ratio stands at 1.97, indicating that the company possesses sufficient current assets to cover its short-term liabilities nearly twice over, suggesting manageable immediate liquidity risks. Return on Equity is calculated at 14.4%, demonstrating effective use of shareholder capital, whereas Return on Assets is 4.0%, reflecting the asset-intensive nature of the hospital and clinic business model where returns are distributed across a large asset base.
Evaluación de valoración
The stock trades with a trailing twelve-month P/E ratio of 9.40 and a forward P/E of 7.71, implying that the market anticipates a compression in valuation multiples or expects earnings growth to outpace revenue growth in the upcoming fiscal periods. The price-to-book ratio is recorded at 1.00, indicating that the market values the company at exactly its book value without applying a significant premium or discount based on intangible assets or brand equity. Alternative valuation metrics include a price-to-sales ratio of 0.20 and an EV/EBITDA multiple of 6.84, which suggests the company is priced at a discount relative to its sales and earnings power compared to high-growth peers. The 52-week trading range spans from a low of $8.07 to a high of $15.48, and the current market price sits at the lower end of this historical band, reflecting recent price weakness or a lack of upward momentum relative to the annual high. The beta value is listed as N/A, meaning that specific volatility data relative to the broader market index is not currently disclosed or applicable in the available data for this specific ticker.
Growth & Income
Revenue growth year-over-year is -0.1%, while earnings growth year-over-year has declined significantly by -60.6%, indicating that earnings are shrinking at a much faster rate than revenue, which points to deteriorating profitability or one-time charges impacting the bottom line. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the firm retains all of its net income to potentially fund operations, reduce debt, or reinvest in the healthcare network rather than distributing cash to shareholders. This retention strategy is typical for capital-intensive healthcare facilities that prioritize expanding their physical footprint or upgrading medical technology over immediate income generation for investors. Consequently, the overall growth and income profile for Ardent Health is currently defined by a contraction in earnings per share and an absence of dividend income, presenting a value-oriented investment case reliant on operational turnaround or efficiency improvements to reverse the negative earnings trajectory.